Akdogan, B. Et Al. 2008. Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study. EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3 , 231.

Akdogan, B., Ozen, H., & Kirdal, Y., (2008). Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study. EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, 231.

Akdogan, B., ABDURRAHİM HALUK ÖZEN, And Y. Kirdal. "Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study," EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, 231, 2008

Akdogan, B. Et Al. "Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study." EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, pp.231, 2008

Akdogan, B. Ozen, H. And Kirdal, Y. (2008) . "Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study." EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, p.231.

@article{article, author={B. Akdogan Et Al. }, title={Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study}, journal={EUROPEAN UROLOGY SUPPLEMENTS}, year=2008, pages={231} }